Skip to nav Skip to content

News

June 20, 2018

 ALL ARTICLES

HIVMA Advocates on Capitol Hill for HIV, Opioid Funding

On June 4, fifteen HIVMA members met with 49 congressional offices in the Senate and House of Representatives, discussing with key staff and committees the need to increase federal funding for HIV programs in FY 2019 and urging Congress to pass opioid response bills related to addressing its infectious diseases consequences. The group also met with the Deputy Assistant Secretary for Health Don Wright, MD, and key staff at the White House Office of Management and Budget to discuss the urgency of incorporating infectious diseases prevention, treatment and providers into the response to the opioid and other substance abuse epidemics.

Rochelle Walensky, MD, FIDSA, HIVMA Board Member and Chief of Infectious Diseases at Massachusetts General Hospital, meets with U.S. Senator Ed Markey (D-MA) during HIVMA Advocacy Day.
Rochelle Walensky, MD, FIDSA, HIVMA Board Member and Chief of 
Infectious Diseases at Massachusetts General meets 
with U.S. Senator Ed Markey (D-MA) during HIVMA Advocacy Day.

 

HIVMA Board Chair Melanie Thompson, MD; Vice Chair Judith Feinberg, MD, FIDSA; and PIDS Liaison Michelle Ogle, MD with Don Wright, MD, MPH.
HIVMA Board Chair Melanie Thompson, MD; 
Vice Chair Judith Feinberg, MD, FIDSA; and
PIDS Liaison Michelle Ogle, MD with Don Wright, MD, MPH.


To get started with your own congressional advocacy in Washington D.C. or in your home district, visit the newly updated IDSA and HIVMA Advocacy Guides for tips and resources. Please reach out with questions to Lisa Cox, IDSA Director of Government Relations or George Fistonich, HIVMA Senior Policy and Advocacy Manager.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.